Treatment Posts on Medivizor
Navigation Menu

Treatment Posts on Medivizor

Is MRD related to treatment and survival in patients with chronic lymphocytic leukemia?

Posted by on Dec 12, 2018 in Leukemia | 0 comments

In a nutshell This study wanted to compare the effectiveness of chlorambucil (Leukeran) plus either obinutuzumab (Gazyva) or rituximab (Rituxan) in the treatment of frail patients with chronic lymphocytic leukemia (CLL). Researchers found that chlorambucil with obinutuzumab (G-Clb) was more effective than with rituximab (R-Clb) in these...

Read More

Survival from transplant of donor bone marrow versus donor blood sample in leukemia treatment

Posted by on Dec 12, 2018 in Leukemia | 0 comments

In a nutshell This study compared the safety and effectiveness of donor peripheral blood (PB) with bone marrow (BM) transplant in the treatment of leukemia. Researchers found that bone marrow transplants are safer and more effective in the treatment of leukemia. Some background Leukemia is a cancer of the bone marrow. It may lead to abnormal immune...

Read More

Rectal cancer: short- and long-term outcomes of robotic assisted laparoscopic surgery

Posted by on Dec 12, 2018 in Colorectal cancer | 0 comments

In a nutshell This article investigated the short- and long-term outcomes of patients with rectal cancer who underwent robotic-assisted laparoscopic surgery (RALS). The authors concluded that RALS is beneficial and has good short- and long-term outcomes.  Some background Conventional laparoscopic surgery (CLS; involves small cuts...

Read More

Effectiveness of dutasteride and solifenacin used to treat benign prostatic hyperplasia

Posted by on Dec 12, 2018 in Benign prostatic hyperplasia | 0 comments

In a nutshell This study aimed to investigate the effects of combining dutasteride (Avodart) and solifenacin (Vesicare) on sexual function in men being treated for benign prostatic hyperplasia (BPH). This study found that the combination of dutasteride and solifenacin does not alter sexual function for men with BPH. Some...

Read More

Adding ixabepilone to capecitabine treatment for triple negative breast cancer.

Posted by on Dec 11, 2018 in Breast cancer | 0 comments

In a nutshell This study wanted to find out if ixabepilone (Ixempra) and capecitabine (Xeloda) work for treating triple-negative breast cancer in patients with hard to treat disease compared to using capecitabine alone. The study found that adding ixabepilone to treatment resulted in longer survival without the cancer progressing. Some background...

Read More

Treating non-small cell lung cancers that have spread.

Posted by on Dec 11, 2018 in Lung cancer | 0 comments

In a nutshell This paper is about how to diagnose, treat, and follow up on non-small cell lung cancer cases that have spread through the body. The paper overall noted that non-small cell lung cancer which has spread is often very aggressive and hard to treat, and that methods of treatment are still being developed.   Some background Non-small...

Read More

Erlotinib in patients with non-small cell lung cancer

Posted by on Dec 11, 2018 in Lung cancer | 0 comments

In a nutshell This study wanted to find out if using the medication erlotinib (Tarceva) in patients with non-small cell lung cancer improved survival. The study found that using erlotinib was safe, and may reduce the need for radical surgery in patients with non-small cell lung cancer. Some background Epidermal growth factor receptor (EGFR) is...

Read More

The effect of drugs that protect nerves in the early stage of diabetic eye disease

Posted by on Dec 11, 2018 in Diabetes mellitus | 0 comments

In a nutshell The aim of this study was to assess whether giving drugs that protect nerves (brimonidine and somatostatin) into the eye can prevent or stop nerve damage in the eye of patients with type 2 diabetes (T2D). The main finding of this study was these drugs protected patients with nerve damage in the eye from the disease worsening. Some...

Read More